Neonatal GALT

A precise fluorometric assay for the quantitative in vitro determination of galactose-1-phosphate uridyltransferase (GALT) activity in dried blood samples. The Neonatal GALT test is designed for the early detection of classic...

Overview

Overview

Accurate enzyme-based screening for early detection of galactosemia. Hereditary galactosemia is a severe disorder of carbohydrate metabolism caused by GALT enzyme deficiency. Without early diagnosis and management, affected newborns can develop liver failure, cataracts, or neurological impairment. The Neonatal GALT test provides a quantitative fluorometric analysis of enzyme activity from dried blood spots, ensuring reliable detection of GALT deficiency. When identified early, simple dietary adjustments—eliminating lactose and galactose—can prevent long-term complications and enable normal development.

Features

Key Features

  • Designed for efficient newborn screening of classic galactosemia
  • Quantitative and reproducible enzyme activity results
  • Assay time of only 30 minutes
  • High stability and reliability across test runs
  • Simplified workflow for high-throughput laboratories

Technical Specifications

  • Format : 10 solid plates (96 wells each)
  • Total Wells : 960
  • Catalogue Number : 6199810

IS Modules

  • Quantitative fluorometric determination of GALT activity
  • Automated plate-to-plate transfer procedure minimizes disc floating interference
  • No false positives due to G6PD deficiency
  • Compatible with both manual and automated proceduress
  • Reduced processing time of 2 hours 30 minutes

Need Guidance?
Our Experts Are Here for You.